PMC:7195088 / 9857-9974 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"169","span":{"begin":20,"end":28},"obj":"Species"},{"id":"241","span":{"begin":11,"end":19},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"Tax:9606"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ically ill COVID-19 patients.\nQuestion 6. Should other immunosuppressive and/or immunomodulatory therapies be adminis"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T50","span":{"begin":11,"end":19},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ically ill COVID-19 patients.\nQuestion 6. Should other immunosuppressive and/or immunomodulatory therapies be adminis"}

{"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":30,"end":41},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ically ill COVID-19 patients.\nQuestion 6. Should other immunosuppressive and/or immunomodulatory therapies be adminis"}